Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 550001 - 550020 out of 553606 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (R03DX05) omalizumab (adm: P) | XOLAIR 75MG/0.5ML INJ,SYR,0.5ML | 0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma;Urticaria;Rhinitis | GenentechUSA,Inc. |
| USA | (R03DX05) omalizumab (adm: P) | XOLAIR 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma;Urticaria;Rhinitis | GenentechUSA,Inc. |
| USA | (R03DX05) omalizumab (adm: P) | XOLAIR 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma;Urticaria;Rhinitis | GenentechUSA,Inc. |
| USA | (R03DX07) roflumilast (adm: O) | ZORYVE 0.3% FOAM,TOP | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ArcutisBiotherapeutics,Inc. |
| USA | (R03DX07) roflumilast (adm: O) | ZORYVE 0.3% CREAM,TOP | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ArcutisBiotherapeutics,Inc. |
| USA | (R03DX07) roflumilast (adm: O) | ZORYVE 0.3% CREAM,TOP | 60GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ArcutisBiotherapeutics,Inc. |
| USA | (R03DX07) roflumilast (adm: O) | ROFLUMILAST 500MCG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 250MCG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 250MCG TAB | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 250MCG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 250MCG TAB | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX07) roflumilast (adm: O) | DALIRESP 500MCG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (R03DX08) reslizumab (adm: P) | CINQAIR(RESLIZUMAB 10MG/ML INJ,SOLN 10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | TevaPharmaceuticalsUSA,Inc. |
| USA | (R03DX08) reslizumab (adm: P) | CINQAIR(RESLIZUMAB 10MG/ML INJ,SOLN 10ML SDV | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | TevaPharmaceuticalsUSA,Inc. |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG/ML,AUTO INJCT | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG/ML,AUTO INJCT | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
| USA | (R03DX09) mepolizumab (adm: P) | NUCALA 100MG/ML,SYRINGE | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Asthma | GlaxoSmithKline |
Pages
